Clinical trial
Electronic Alert-Based Computerized Decision Support to Increase Prescription of Anticoagulation in High-Risk Atrial Fibrillation Patients in the Outpatient Setting (AF-ALERT2)
NCT02958943 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electronic Alert-Based Computerized Decision Support to Increase Prescription of Anticoagulation in High-Risk Atrial Fibrillation Patients in the Outpatient Setting (AF-ALERT2)
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2018
- Completion date
- June 30, 2022
- Enrollment
- 798 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.